What is Affera?
Affera is a medical technology company focused on innovating solutions for the burgeoning cardiac arrhythmia market. The company is developing an integrated platform designed to efficiently deliver durable therapies to a wide range of cardiac arrhythmia patients. This comprehensive approach aims to streamline treatment processes and improve patient outcomes in a critical healthcare segment.
How much funding has Affera raised?
Affera has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Affera
PPP
Public-Private Partnership
What's next for Affera?
With its large-scale late-stage funding and a recent major strategic investment, Affera is positioned for significant growth and expansion. The company is likely to leverage this capital to further refine its integrated platform, scale manufacturing capabilities, and broaden its market reach. Strategic partnerships and clinical validation will be key as Affera aims to establish a dominant presence in the cardiac arrhythmia solutions space.
See full Affera company page
